![Glen Clack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glen Clack
Directeur Technique/Scientifique/R&D chez
THERACRYF PLC
Profil
Glen Clack is currently Chief Medical Officer at TheraCryf Plc since 2021.
Dr. Clack holds a doctorate from The University of Sheffield and an undergraduate degree from Royal Free Hospital School of Medicine.
Postes actifs de Glen Clack
| Sociétés | Poste | Début |
|---|---|---|
| THERACRYF PLC | Directeur Technique/Scientifique/R&D | 01/05/2021 |
Formation de Glen Clack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Free Hospital School of Medicine
 Royal Free Hospital School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
